JPND call for proposals: "Multinational research projects on Health and Social Care for Neurodegenerative Diseases"


Convocatòria tancada
Entitat convocant:
European Commission
Àmbit:
Internacional
Inici:
Termini intern:
Termini real:
Descripció:

Objectiu de la convocatòria


The EU Joint Programme on Neurodegenerative Disease Research (JPND) was established in order to better coordinate research efforts across countries and disciplines to more rapidly find causes, develop cures and identify better ways to care for people with neurodegenerative disease. The JPND Research Strategy, published in 2012, identified research priorities and provided a framework for future investment.

 

Característiques principals


The aim of the call is to establish a limited number of ambitious, innovative, multi-national and multi-disciplinary collaborative research projects that address health and social care delivery at the macro level (system and infrastructures) as well as (at) the individual level of patients, their carers and families. Evaluating the strengths and weaknesses of formal and informal care approaches and existing infrastructures is a prelude to implementing improved, evidence-based approaches and thereby improving the quality of life for those affected by neurodegenerative diseases and the quality of care.

 

>Proposals on health and social care can apply to patients with any or several of the following neurodegenerative diseases:

  • Alzheimer’s disease and other dementias
  • Parkinson’s disease and PD‐related disorders
  • Prion diseases
  • Motor neuron diseases
  • Huntington’s disease
  • Spinocerebellar ataxia (SCA)
  • Spinal muscular atrophy (SMA)

    >Proposals submitted under this call will include, but are not limited to, the research areas listed below. Proposals can focus on one or several of these areas:
  • Care pathways and services using the potential of patient involvement
  • Factors influencing progression and prognosis of disease
  • Outcome measures for patients and their informal carers
  • Palliative care of patients
  • Cost-effectiveness and affordability of interventions including ethical concerns
  •  

    Requisits

    Each proposal must involve a minimum of three and a maximum of six regular partners from at least three different countries participating in this call. If the proposal involves at least one regular partner from an underrepresented European country (Czech Republic, Poland, Slovakia), the maximum number of regular partners is extended to seven partners. For reasons of transnational balance, no more than two regular partners from the same country are allowed to join a proposal.

    Eligible countries:Australia, Belgium, Canada, Czech Republic, Denmark, Finland, France, Germany, Ireland, Italy, Luxembourg, The Netherlands, Norway, Poland, Slovakia, Spain, Sweden, Switzerland, Turkey, United Kingdom.

    In addition, external collaborators (e.g., research groups from countries that are not participating in this call or research groups that do not apply for funding) may participate in proposals. External collaborators must be able to secure their own funding.

    Whilst proposals are to be submitted jointly by research groups from different countries, individual regular partners will be funded by the corresponding funding organisation participating in this call. In consequence, eligibility for funding is decided by the respective funding organisations and details of what may or may not be funded are subject to the specific regulations of these funding organisations and thus may vary.

     

    Dotació


    For Spanish participants:

  • Up to 150.000 € per partner (overheads included)
  • Up to 200.000 € per coordinator (overheads included)

  • Durada
    3 years